CLINICAL TRIALS PROFILE FOR BETOPTIC S
✉ Email this page to a colleague
All Clinical Trials for BETOPTIC S
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00061542 ↗ | Safety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-forming Solution 0.25% and 0.5% in Pediatric Patients With Glaucoma or Ocular Hypertension | Completed | Alcon Research | Phase 3 | 2003-01-01 | The purpose of this study is to evaluate the safety and efficacy of BETOPTIC S and Timolol Gel-forming solution in pediatric patients. Patients will dose with study drug at 8 am and 8 pm daily for twelve weeks. Patients will have vision tested, slit lamp exam, blood pressure and pulse checks at each visit. Patients will have a dilated fundus exam and corneal measurements taken at first and last visit. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for BETOPTIC S
Condition Name
Clinical Trial Locations for BETOPTIC S
Trials by Country
Clinical Trial Progress for BETOPTIC S
Clinical Trial Phase
Clinical Trial Sponsors for BETOPTIC S
Sponsor Name